Literature DB >> 29346634

Are people getting quality thalassemia care in twin cities of Pakistan? A comparison with international standards.

Tehreem Tanveer1, Haleema Masud1,2, Zahid Ahmed Butt1,3.   

Abstract

OBJECTIVES: This study was conducted to determine if thalassemia patients were getting quality care in Rawalpindi and Islamabad, Pakistan, as per international standards and to identify determinants for better quality of thalassemia care.
DESIGN: A cross sectional study was conducted using interview based structured questionnaire, which was developed using standards of thalassemia care used by International Thalassemia Foundation.
SETTING: Five healthcare facilities catering to the needs of thalassemia patients in Rawalpindi and Islamabad, Pakistan. PARTICIPANTS: Data were collected from 315 thalassemia patients from May to August, 2016. MAIN OUTCOME MEASURE: Survey data on quality indicators.
RESULTS: Results showed that almost half of thalassemia patients (48.5%) were getting poor quality of care. On average patients were getting only 63.93% of possible quality care for the disease. The most deficient quality area was management of complications where patients were getting only 49.1% of possible care. Better quality of care was likely to be received by those patients who were educated, patients with educated fathers, those visiting private facilities and those who were visiting facilities in Islamabad. Those with concomitant diseases were also likely to receive better care.
CONCLUSION: Quality of care provided to thalassemia patients was well below the international standards for the care of thalassemia. There is a need to take urgent action to improve quality of care in the country.

Entities:  

Mesh:

Year:  2018        PMID: 29346634     DOI: 10.1093/intqhc/mzx198

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  4 in total

Review 1.  Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment.

Authors:  Gibran Ali; Muhammad Akram Tariq; Kamran Shahid; Fridoon Jawad Ahmad; Javed Akram
Journal:  Gene Ther       Date:  2020-04-30       Impact factor: 5.250

2.  Sociodemographic determinants associated with parental knowledge of screening services for thalassemia major in Lahore.

Authors:  Iram Manzoor; Rubeena Zakar
Journal:  Pak J Med Sci       Date:  2019 Mar-Apr       Impact factor: 1.088

3.  Experience of Uncertainty in Patients with Thalassemia Major: A Qualitative Study.

Authors:  Mehrnaz Ahmadi; Mahin Gheibizadeh; Maryam Rassouli; Abbas Ebadi; Marziyeh Asadizaker; Mojtaba Jahanifar
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-10-01

4.  Impact of COVID-19 restrictions on healthcare delivery for thalassemia major patients: A perspective from Pakistan.

Authors:  Mohammad Ebad Ur Rehman; Beenish Sabir; Faizan Fazal; Junaid Tanveer; Tehseen Haider; Abdul Rauf Khalid; Sajeel Saeed; Jawad Basit
Journal:  Ann Med Surg (Lond)       Date:  2022-09-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.